Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.7 |
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |